Dr. Véronique L. Roger is a distinguished cardiovascular epidemiologist renowned for her comprehensive research on the epidemiology of heart diseases and their population-level impact. She currently serves as Senior Investigator and founding Chief of the Epidemiology and Community Health Branch at the National Heart, Lung, and Blood Institute of the National Institutes of Health. Dr. Roger received her medical degree in 1986 from Sorbonne University in Paris, France and earned a Master in Public Health in Epidemiology from the University of Minnesota in 1996 following her cardiology training at Mayo Clinic. She joined the Mayo Clinic faculty in 1992 where she rose to Professor in Medicine and Epidemiology, held leadership roles including Chair of the Department of Health Sciences Research, and served on the Mayo Clinic Board of Governors and Board of Trustees.
Dr. Roger's research program integrates epidemiology, outcomes assessment, healthcare delivery analysis, and behavioral sciences to investigate the occurrence and outcomes of cardiovascular diseases in community settings. Her innovative use of electronic health records in population research has advanced methodologies for case ascertainment, risk prediction, and pragmatic trials, establishing new standards in cardiovascular epidemiology. She has been continuously funded by the NIH for over two decades, with her work providing critical insights into the evolving burden of cardiovascular diseases across populations. Her laboratory at NHLBI focuses on understanding the phenotypic expressions of heart failure through molecular taxonomy using proteomics and examining connections with aging, multimorbidity, and social determinants of health.
As a recognized leader in cardiovascular research, Dr. Roger chaired the Epidemiology Council of the American Heart Association from 2018-2020 and was honored as an American Heart Association Distinguished Investigator in 2019. She serves as senior investigator and chief of the Laboratory of Heart Disease Phenomics at NHLBI, where her current research centers on the alarming reversal in heart disease mortality trends due to increasing heart failure deaths since 2015. Her work employs multi-omics approaches and advanced analytical methods such as machine learning to enhance heart failure risk assessment and pave the way for precision interventions. Dr. Roger continues to shape the field through her leadership in national studies and her commitment to addressing the unresolved heart failure epidemic through molecular and population health approaches.
